Did you know how SGLT2 inhibitors protect the kidney?

Acta Physiol (Oxf). 2023 Aug;238(4):e14011. doi: 10.1111/apha.14011. Epub 2023 Jun 18.

Authors

Anita T Layton^{1

2}, Volker Vallon^{3

4}

Affiliations

¹ Departments of Applied Mathematics and Biology, University of Waterloo, Waterloo, Ontario, Canada.
² Cheriton School of Computer Science, School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
³ Departments of Medicine and Pharmacology, University of California, San Diego, La Jolla, California, USA.
⁴ San Diego Veterans Affairs Healthcare System, San Diego, California, USA.

PMID: 37288493
DOI: 10.1111/apha.14011

No abstract available

Publication types

Editorial

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents
Kidney
Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors
Hypoglycemic Agents